Critical to the continual improvement of cryoablation efficacy is deciphering the biochemical responses of cells to low-temperature exposure. The identification of delayed-onset cell death has ...

The efficacy of cryoablation in ablating human tissues is well established based on histopathologic studies. This technique has been associated with a relatively high incidence of impotence ...

An individual who has kidney cancer and who is unable to undergo a surgical procedure to remove their malignancy may need to have cryoablation as part of their treatment. Numerous health ...

The ProSense® Cryoablation System is a minimally invasive ... destruction in benign and cancerous lesions, including breast, kidney, lung, and liver. ProSense® enhances patient and provider ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

Icecure Medical ( ($ICCM) ) has issued an update. IceCure Medical participated in the 2025 Society of Interventional Oncology Annual Meeting, ...